Epidemiologic studies are needed for monitoring population-level trends in sepsis. This study examines sepsis-causing microorganisms from 2006 to 2014 in the United States using data from the Nationwide Inpatient Sample database.
Methods
7 860 686 adults hospitalized with sepsis were identified using a validated ICD-9 coding approach. Associated microorganisms were identified by ICD-9 code and classified by major groups (Gram-positive, Gram-negative, fungi, anaerobes) and specific species for analysis of their incidence and mortality.
Results
The rate of sepsis incidence has increased for all four major categories of pathogens, while the mortality rate decreased. In 2014, Gram-negative pathogens had a higher incidence than Gram-positives. Anaerobes increased the fastest with an average annual increase of 20.17% (p < 0.001). Fungi had the highest mortality (19.28%) and the slowest annual decrease of mortality (−2.31%, p = 0.006) in 2013, while anaerobic sepsis had the highest hazard of mortality (adjusted HR 1.60, 95% CI 1.53-1.66).
Conclusions
Gram-negative pathogens have replaced Gram-positives as the leading cause of sepsis in the United States in 2014 during the study period (2006-2014). The incidence of anaerobic sepsis has an annual increase of 20%, while the mortality of fungal sepsis has not decreased at the same rate as other microorganisms. These findings should inform the diagnosis and management of septic patients, as well as the implementation of public health programs.
VincentJ-LOpalSMMarshallJCTraceyKJ. Sepsis definitions: time for change. Lancet Lond Engl. 2013;381(9868):774-775. doi:10.1016/S0140-6736(12)61815-7
2.
WiersingaWJLeopoldSJCranendonkDRvan der PollT. Host innate immune responses to sepsis. Virulence. 2014;5(1):36-44. doi:10.4161/viru.25436
3.
GaieskiDFEdwardsJMKallanMJCarrBG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41(5):1167-1174. doi:10.1097/CCM.0b013e31827c09f8
4.
KumarGKumarNTanejaA, et al. Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest. 2011;140(5):1223-1231. doi:10.1378/chest.11-0352
5.
YoC-HLaiC-CHsuT-C, et al. National trends of organ dysfunctions in sepsis: an 11-year longitudinal population-based cohort study. J Acute Med. 2019;9(4):178-188. doi:10.6705/j.jacme.201912_9(4).0004
6.
RiversENguyenBHavstadS, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368-1377. doi:10.1056/NEJMoa010307
7.
SingerMDeutschmanCSSeymourCW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287
8.
MartinGSManninoDMEatonSMossM. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546-1554. doi:10.1056/NEJMoa022139
9.
BaldoVCocchioSGalloT, et al. Pneumococcal conjugated vaccine reduces the high mortality for community-acquired pneumonia in the elderly: an Italian regional experience. PloS One. 2016;11(11):e0166637. doi:10.1371/journal.pone.0166637
10.
RheeCDantesREpsteinL, et al. Incidence and trends of sepsis in US hospitals using clinical versus claims data, 2009-2014. JAMA. 2017;318(13):1241-1249. doi:10.1001/jama.2017.13836
11.
LangleyGSchaffnerWFarleyMM, et al. Twenty years of active bacterial core surveillance. Emerg Infect Dis. 2015;21(9):1520-1528. doi:10.3201/eid2109.141333
12.
HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). 2011. Agency for Healthcare Research and Quality, Rockville, MD. Accessed July 11, 2021.https://www.hcup-us.ahrq.gov/nisoverview.jsp
13.
SehgalMLaddHJTotapallyB. Trends in epidemiology and microbiology of severe sepsis and septic shock in children. Hosp Pediatr. 2020;10(12):1021-1030. doi:10.1542/hpeds.2020-0174
14.
LiuMABakowBRHsuT-C, et al. Temporal trends in sepsis incidence and mortality in patients With cancer in the US population. Am J Crit Care Off Publ Am Assoc Crit-Care Nurses. 2021;30(4):e71-e79. doi:10.4037/ajcc2021632
15.
MooreBJWhiteSWashingtonRCoenenNElixhauserA. Identifying increased risk of readmission and In-hospital mortality using hospital administrative data: the AHRQ Elixhauser Comorbidity Index. Med Care. 2017;55(7):698-705. doi:10.1097/MLR.0000000000000735
16.
GotoTYoshidaKTsugawaYFilbinMRCamargoCAHasegawaK. Mortality trends in U.S. adults with Septic shock, 2005-2011: a serial cross-sectional analysis of nationally-representative data. BMC Infect Dis. 2016;16:294. doi:10.1186/s12879-016-1620-1
17.
KaukonenK-MBaileyMSuzukiSPilcherDBellomoR. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014;311(13):1308-1316. doi:10.1001/jama.2014.2637
18.
EsperAMMartinGS. Extending international sepsis epidemiology: the impact of organ dysfunction. Crit Care Lond Engl. 2009;13(1):120. doi:10.1186/cc7704
19.
HarrisonDAWelchCAEddlestonJM. The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database. Crit Care Lond Engl. 2006;10(2):R42. doi:10.1186/cc4854
MayrFBYendeSAngusDC. Epidemiology of severe sepsis. Virulence. 2014;5(1):4-11. doi:10.4161/viru.27372
22.
RuddKEJohnsonSCAgesaKM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study. Lancet Lond Engl. 2020;395(10219):200-211. doi:10.1016/S0140-6736(19)32989-7
23.
Brun-BuissonCDoyonFCarletJ. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French bacteremia-sepsis study group. Am J Respir Crit Care Med. 1996;154(3 Pt 1):617-624. doi:10.1164/ajrccm.154.3.8810595
24.
SievertDMRicksPEdwardsJR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2009-2010. Infect Control Hosp Epidemiol. 2013;34(1):1-14. doi:10.1086/668770
25.
HidronAIEdwardsJRPatelJ, et al.NHSN Annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29(11):996-1011. doi:10.1086/591861
26.
AlbrechtSJFishmanNOKitchenJ, et al. Reemergence of gram-negative health care-associated bloodstream infections. Arch Intern Med. 2006;166(12):1289-1294. doi:10.1001/archinte.166.12.1289
27.
MaschmeyerGHaasACornelyOA. Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs. 2007;67(11):1567-1601. doi:10.2165/00003495-200767110-00004
28.
PittetDWenzelRP. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med. 1995;155(11):1177-1184. doi:10.1001/archinte.155.11.1177
29.
ClevelandAAHarrisonLHFarleyMM, et al. Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008-2013: results from population-based surveillance. PLoS One. 2015;10(3):e0120452. doi:10.1371/journal.pone.0120452
30.
NguyenMHPeacockJEMorrisAJ, et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med. 1996;100(6):617-623. doi:10.1016/s0002-9343(95)00010-0
31.
MartinGS. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther. 2012;10(6):701-706. doi:10.1586/eri.12.50
32.
LassmannBGustafsonDRWoodCMRosenblattJE. Reemergence of anaerobic bacteremia. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;44(7):895-900. doi:10.1086/512197
33.
LeiboviciL. Bacteraemia in the very old. Features and treatment. Drugs Aging. 1995;6(6):456-464. doi:10.2165/00002512-199506060-00005
34.
FennerLWidmerAFStraubCFreiR. Is the incidence of anaerobic bacteremia decreasing? Analysis of 114 000 blood cultures over a ten-year period. J Clin Microbiol. 2008;46(7):2432-2434. doi:10.1128/JCM.00013-08
35.
BrookIFrazierEH. Aerobic and anaerobic infection associated with malignancy. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 1998;6(2):125-131. doi:10.1007/s005200050146
36.
LarkRLMcNeilSAVanderHydeKNooraniZUbertiJChenowethC. Risk factors for anaerobic bloodstream infections in bone marrow transplant recipients. Clin Infect Dis Off Publ Infect Dis Soc Am. 2001;33(3):338-343. doi:10.1086/322595
37.
TonneauMElkriefAPasquierD, et al. The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: a systematic review. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2021;156(3):1-9. doi:10.1016/j.radonc.2020.10.033
38.
DeenJvon SeidleinLAndersenFElleNWhiteNJLubellY. Community-acquired bacterial bloodstream infections in developing countries in south and Southeast Asia: a systematic review. Lancet Infect Dis. 2012;12(6):480-487. doi:10.1016/S1473-3099(12)70028-2
39.
Mughini-GrasLPijnackerRDuijsterJ, et al. Changing epidemiology of invasive non-typhoid Salmonella infection: a nationwide population-based registry study. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2020;26(7):941.e9-941.e14. doi:10.1016/j.cmi.2019.11.015
40.
WangXBiswasSPaudyalN, et al. Corrigendum: antibiotic resistance in Salmonella Typhimurium isolates recovered from the food chain through national antimicrobial resistance monitoring system between 1996 and 2016. Front Microbiol. 2020;11:1738. doi:10.3389/fmicb.2020.01738
41.
KarlowskyJAWalktyAJAdamHJBaxterMRHobanDJZhanelGG. Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD surveillance study. Antimicrob Agents Chemother. 2012;56(3):1247-1252. doi:10.1128/AAC.05823-11
WagenvoortGHJKnolMJde MelkerHE, et al. Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands. Vaccine. 2016;34(3):334-340. doi:10.1016/j.vaccine.2015.11.048
44.
KadriSSRheeCStrichJR, et al. Estimating Ten-year trends in septic shock incidence and mortality in United States academic medical centers using clinical data. Chest. 2017;151(2):278-285. doi:10.1016/j.chest.2016.07.010
45.
RhodesAPhillipsGBealeR, et al. The surviving sepsis campaign bundles and outcome: results from the international multicentre prevalence study on sepsis (the IMPreSS study). Intensive Care Med. 2015;41(9):1620-1628. doi:10.1007/s00134-015-3906-y
46.
InvestigatorsProCESSYealyDMKellumJA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683-1693. doi:10.1056/NEJMoa1401602
47.
LabelleAJMicekSTRoubinianNKollefMH. Treatment-related risk factors for hospital mortality in Candida bloodstream infections. Crit Care Med. 2008;36(11):2967-2972. doi:10.1097/CCM.0b013e31818b3477
48.
HeckenbergSGBde GansJBrouwerMC, et al. Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine (Baltimore). 2008;87(4):185-192. doi:10.1097/MD.0b013e318180a6b4
49.
BrooksRWoodsCWBenjaminDKRosensteinNE. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002. Clin Infect Dis Off Publ Infect Dis Soc Am. 2006;43(1):49-54. doi:10.1086/504804
50.
MacNeilJRBlainAEWangXCohnAC. Current epidemiology and trends in meningococcal disease-United States, 1996-2015. Clin Infect Dis Off Publ Infect Dis Soc Am. 2018;66(8):1276-1281. doi:10.1093/cid/cix993
51.
SeymourCWGestenFPrescottHC, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017;376(23):2235-2244. doi:10.1056/NEJMoa1703058
52.
MorrellMFraserVJKollefMH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005;49(9):3640-3645. doi:10.1128/AAC.49.9.3640-3645.2005
53.
WuM-HTsouP-YWangY-H, et al. Impact of post-sepsis cardiovascular complications on mortality in sepsis survivors: a population-based study. Crit Care Lond Engl. 2019;23(1):293. doi:10.1186/s13054-019-2579-2
54.
RheeCMurphyMVLiLPlattRKlompasM, Centers for disease control and prevention epicenters program. Comparison of trends in sepsis incidence and coding using administrative claims versus objective clinical data. Clin Infect Dis Off Publ Infect Dis Soc Am. 2015;60(1):88-95. doi:10.1093/cid/ciu750
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
